Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today applauded the President's Fiscal Year 2027 budget proposal for its significant investments in advanced manufacturing technologies ...
The Danish drugmaker becomes the latest major pharmaceutical company to embed AI across its entire drug development pipeline, ...
Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
For Astellas’ chief manufacturing officer Rao Mantri, Ph.D.—who entered the position a little over a year ago—production is ...
Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Although last week’s extensive tariff announcements ...
Deloitte has noted that digital transformation in life sciences manufacturing can boost operational efficiency by streamlining processes, increasing productivity and reducing errors. AI systems can ...
The pharma industry “own Congress, they own the media,” Health Secretary Robert F. Kennedy, Jr. told lawmakers by way of ...
Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton, Va. The new site is expected to create 500 jobs, Virginia Gov. Glenn Youngkin and the company announced at a ...
Zacks Investment Research on MSN
Reasons to retain West Pharmaceutical stock in your portfolio for now
West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug ...
President Trump has reached a trade agreement with the European Union, imposing a 15 percent tariff on most items. However, the president said that pharmaceuticals are excluded from the agreement, ...
In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...
The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price ...
Although Bangladeshi drug manufacturers currently have several months’ worth of raw materials in stock and face no immediate supply disruption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results